Skip to main content
. Author manuscript; available in PMC: 2022 Apr 14.
Published in final edited form as: Neurorehabil Neural Repair. 2022 Feb 14;36(4-5):286–297. doi: 10.1177/15459683221076461

Table 1.

Baseline demographic and clinical characteristics in the two study groups.

Multiple Sclerosis (N=15) Healthy Controls (N=22) p

Age (years; M, SD) 60.9 (5.1) 64.2 (5.7) 0.084
Sex 0.683
 Women (n, %) 13 (86.7) 19 (86.4)
 Men (n, %) 2 (13.3) 3 (13.6)
Race 0.389
 White (n, %) 13 (86.7) 15 (68.2)
 Black (n, %) 2 (13.3) 6 (27.3)
 Hispanic (n, %) 0 (0.0) 1 (4.6)
BMI 28.00 (5.6) 27.9 (6.1) 0.960
Disease Duration (years; M, SD) 19.2 (5.0) -
EDSS (median, IQR) 4.0 (1.0) -
T25FW (ft/s; M, SD) 4.5 (1.5) 6.1 (0.9) <0.001
6MW (ft; M, SD) 1393.6 (426.7) 1858.4 (300.8) <0.001

6MW=Six-Minute Walk; BMI=body mass index; IQR=interquartile range; EDSS=Expanded Disability Status Scale; M=mean; SD=standard deviations; T25FW=Timed 25-foot Walk